You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma

Article metrics

Article menu

Download PDFPDF

XML
Basic tumor immunology
Original research
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: August 2020 to November 2025

AbstractFullPdf
Aug 2020573573147
Sep 2020971971181
Oct 202037737763
Nov 202025625859
Dec 202026226272
Jan 202138838864
Feb 202113213246
Mar 202114614661
Apr 202110210257
May 202110210256
Jun 202111010959
Jul 202110810868
Aug 202113313371
Sep 202110310342
Oct 202116016083
Nov 202119919780
Dec 202110510547
Jan 20229810346
Feb 202211812067
Mar 202215518379
Apr 2022147156151
May 202215215662
Jun 202213613956
Jul 202212712957
Aug 202214414659
Sep 202212512989
Oct 202211011967
Nov 202210810847
Dec 202212012548
Jan 2023707024
Feb 202313413761
Mar 202312012055
Apr 2023747643
May 2023929228
Jun 2023757531
Jul 2023747545
Aug 2023737333
Sep 2023565620
Oct 2023858745
Nov 2023828532
Dec 2023767639
Jan 2024787939
Feb 2024656537
Mar 2024999980
Apr 2024646739
May 2024677639
Jun 2024697336
Jul 2024788433
Aug 2024545828
Sep 2024585831
Oct 2024606227
Nov 2024737428
Dec 2024889024
Jan 2025737438
Feb 2025676738
Mar 2025535334
Apr 2025676730
May 2025616128
Jun 2025626217
Jul 2025110
Sep 2025110
Nov 2025110
Total801781333166